Paper41869728
Macrophages expressing macrophage receptor with collagen structure attenuate liver fibrosis through a tissue restoration phenotype.
Jerez S and 16 others. JCI Insight, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Macrophages expressing macrophage receptor with collagen structure attenuate liver fibrosis through a tissue restoration phenotype. Papers, record 41869728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41869728
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Macrophages expressing macrophage receptor with collagen structure attenuate liver fibrosis through a tissue restoration phenotype.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macrophages | Major topic |
| Liver Cirrhosis | Major topic |
| Collagen | Major topic |
| Receptors, Immunologic | Major topic |
| Animals | |
| Mice | |
| Hepatic Stellate Cells | |
| Liver | |
| Phenotype | |
| Male | |
| Disease Models, Animal | |
| Phagocytosis | |
| Mice, Inbred C57BL | |
| Humans |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33960559 | Transplantation of tauroursodeoxycholic acid-inducing M2-phenotype macrophages promotes an anti-neuroinflammatory effect and functional recovery after spinal cord injury in rats. | Cell Prolif | 2021 | https://conductscience.org/library/papers/33960559 | PubMed |
| 2 | 20162551 | A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses. | Eur J Immunol | 2010 | https://conductscience.org/library/papers/20162551 | PubMed |
| 3 | 34750149 | Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). | BMJ Open | 2021 | https://conductscience.org/library/papers/34750149 | PubMed |
| 4 | 24431111 | Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24431111 | PubMed |
| 5 | 32240619 | Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4-/- Mouse. | Am J Pathol | 2020 | https://conductscience.org/library/papers/32240619 | PubMed |
| 6 | 25953850 | Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure. | FASEB J | 2015 | https://conductscience.org/library/papers/25953850 | PubMed |
| 7 | 34572315 | MARCO+ Macrophage Dynamics in Regenerating Liver after 70% Liver Resection in Mice. | Biomedicines | 2021 | https://conductscience.org/library/papers/34572315 | PubMed |
| 8 | 33363539 | Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline Structures. | Front Immunol | 2020 | https://conductscience.org/library/papers/33363539 | PubMed |
| 9 | 38526524 | Fetal liver macrophages contribute to the hematopoietic stem cell niche by controlling granulopoiesis. | Elife | 2024 | https://conductscience.org/library/papers/38526524 | PubMed |
| 10 | 38967563 | Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context. | Hepatol Commun | 2024 | https://conductscience.org/library/papers/38967563 | PubMed |
| 11 | 33219516 | Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections. | Hepatology | 2021 | https://conductscience.org/library/papers/33219516 | PubMed |
| 12 | 36773567 | MARCO is a potential prognostic and immunotherapy biomarker. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/36773567 | PubMed |
| 13 | 36934284 | UGRP1-modulated MARCO+ alveolar macrophages contribute to age-related lung fibrosis. | Immun Ageing | 2023 | https://conductscience.org/library/papers/36934284 | PubMed |
| 14 | 39134804 | CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. | Cell Mol Immunol | 2024 | https://conductscience.org/library/papers/39134804 | PubMed |
| 15 | 23246690 | Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23246690 | PubMed |
| 16 | 39136031 | Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39136031 | PubMed |
| 17 | 38065400 | Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38065400 | PubMed |
| 18 | 26945878 | Targeting of EMILIN-1 and EMILIN-2 to Fibrillin Microfibrils Facilitates their Incorporation into the Extracellular Matrix. | J Invest Dermatol | 2016 | https://conductscience.org/library/papers/26945878 | PubMed |
| 19 | 33426702 | Adoptive transfer of immunomodulatory M2 macrophages suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice via blockading NF-κB pathway. | Clin Exp Immunol | 2021 | https://conductscience.org/library/papers/33426702 | PubMed |
| 20 | 34177948 | Hepatic Macrophage Responses in Inflammation, a Function of Plasticity, Heterogeneity or Both? | Front Immunol | 2021 | https://conductscience.org/library/papers/34177948 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41869728
GET https://conductscience.org/api/papers/v1/41869728/references?page=2